Cargando…
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
Pancreatic cancer has an extremely poor prognosis, and identification of novel predictors of therapeutic efficacy and prognosis is urgently needed. Chemoresistance-related molecules are correlated with poor prognosis and may be effective targets for cancer treatment. Here, we aimed to identify novel...
Autores principales: | Ohkuma, Ryotaro, Yada, Erica, Ishikawa, Shumpei, Komura, Daisuke, Ishizaki, Hidenobu, Tamada, Koji, Kubota, Yutaro, Hamada, Kazuyuki, Ishida, Hiroo, Hirasawa, Yuya, Ariizumi, Hirotsugu, Satoh, Etsuko, Shida, Midori, Watanabe, Makoto, Onoue, Rie, Ando, Kiyohiro, Tsurutani, Junji, Yoshimura, Kiyoshi, Yokobori, Takehiko, Sasada, Tetsuro, Aoki, Takeshi, Murakami, Masahiko, Norose, Tomoko, Ohike, Nobuyuki, Takimoto, Masafumi, Izumizaki, Masahiko, Kobayashi, Shinichi, Tsunoda, Takuya, Wada, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953839/ https://www.ncbi.nlm.nih.gov/pubmed/31923206 http://dx.doi.org/10.1371/journal.pone.0226707 |
Ejemplares similares
-
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer
por: Ohkuma, Ryotaro, et al.
Publicado: (2020) -
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer
por: Ohkuma, Ryotaro, et al.
Publicado: (2020) -
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies
por: Ohkuma, Ryotaro, et al.
Publicado: (2021) -
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report
por: Hamada, Kazuyuki, et al.
Publicado: (2022) -
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy
por: Hirasawa, Yuya, et al.
Publicado: (2021)